This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Axalta (AXTA) Earnings Lag Estimates, Revenues Beat in Q4
by Zacks Equity Research
Axalta (AXTA) benefits from higher average price and product mix amid headwinds from limitations in the availability for major raw materials in Q4.
Axalta Coating Systems (AXTA) Q4 Earnings Miss Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of -3.23% and 0.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Axalta Coating Systems (AXTA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axalta Coating Systems (AXTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axalta Coating Systems (AXTA) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 18.18% and -0.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Axalta Coating Systems (AXTA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Axalta Coating Systems (AXTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axalta (AXTA) Launches Imron HPU DTM Primer, Boosts Portfolio
by Zacks Equity Research
Axalta's (AXTA) Imron Industrial HPU DTM primer showcases the added value and diversification of its Imron Industrial portfolio.
Axalta (AXTA) Updates View on Supply Chain & Input Constraints
by Zacks Equity Research
Axalta (AXTA) anticipates adjusted EBIT in the $130-140 million range. It expects net sales to decline roughly $40 million compared with earlier-announced volume levels.
Axalta (AXTA) to Display Coatings at the Novi Battery Show
by Zacks Equity Research
Axalta (AXTA) will also unveil its new Plascoat thermoplastic powder that prevents corrosion, dielectric, stone chip and fire in a single layer of coating.
Axalta Coating Systems (AXTA) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 4.35% and 3.93%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
AXTA or DSEY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXTA vs. DSEY: Which Stock Is the Better Value Option?
Axalta (AXTA) to Acquire U-POL Holdings for $590 Million
by Zacks Equity Research
Axalta (AXTA) is expected to speed up growth of U-POL's products by expanding market access through its existing sales and distribution channels.
AXTA or DSEY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXTA vs. DSEY: Which Stock Is the Better Value Option?
5 Top Specialty Chemical Stocks to Buy on End-Market Strength
by Anindya Barman
An upturn in demand across major end-markets such as construction and automotive instills optimism in the specialty chemical space. VVV, ESI, NGVT, AXTA and KWR are worth betting on right now.
AXTA or DSEY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXTA vs. DSEY: Which Stock Is the Better Value Option?
American Vanguard (AVD) to Acquire Envoke Herbicide From Syngenta
by Zacks Equity Research
The addition of Envoke to American Vanguard's (AVD) unit AMVAC's portfolio allows it to reinforce its portfolio in core crops.
Ingevity (NGVT) Announces Price Hike of Chemical-Based Products
by Zacks Equity Research
Ingevity's (NGVT) price hike is due to continued strong market demand as well as rising raw materials and logistics costs.
AXTA vs. NVZMY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AXTA vs. NVZMY: Which Stock Is the Better Value Option?
AXTA vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AXTA vs. ECL: Which Stock Is the Better Value Option?
Axalta Coating Systems (AXTA) Upgraded to Buy: Here's Why
by Zacks Equity Research
Axalta Coating Systems (AXTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Momentum Investors Will Love Axalta Coating Systems (AXTA)
by Zacks Equity Research
Does Axalta Coating Systems (AXTA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Axalta Coating Systems (AXTA) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 19.05% and 3.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Axalta Coating Systems (AXTA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Axalta Coating Systems (AXTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LyondellBasell (LYB) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) Q4 performance is likely to have benefited from higher demand for polyethylene.
Axalta Coating Systems (AXTA) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Axalta Coating Systems (AXTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Quaker Chemical (KWR) Looks Good: Stock Adds 5.1% in Session
by Zacks Equity Research
Quaker Chemical (KWR) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.